|
COPYRIGHT 2001 PR Newswire Association LLC
Rapid Point-of-Care Tests Intended to Improve Patient Outcomes
GAITHERSBURG, Md., May 31 /PRNewswire/ --
IGEN International Inc. (Nasdaq: IGEN) announced today that it is moving to expand the market for its PATHIGEN(TM) test kits, currently used to screen food for potentially harmful bacteria, by adapting the kits for use in rapid tests for human gastrointestinal infections in point-of-care settings, such as physicians' offices and satellite laboratories in hospitals.
The technical feasibility of such adaptation was the subject of a presentation last week at the annual meeting of the American Society of Microbiology in Orlando, Fla. IGEN scientists reported the results of a study demonstrating that PATHIGEN tests detected two kinds of foodborne pathogens, Salmonella and Campylobacter, in human fecal samples without the need to grow the bacteria for 24...
Read the full article for free courtesy of your local library.
|
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
